Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Pharmacoeconomics
|
August 9, 2021
Cost Effectiveness of Triplet Selinexor-Bortezomib-Dexamethasone (XVd) in Previously Treated Multiple Myeloma (MM) Based on Results from the Phase III BOSTON Trial
Michael Dolph, Gabriel Tremblay, Hoyee Leong
Journal of Health Economics and Outcomes Research
|
October 7, 2021
Network Meta-Analysis of Once Weekly Selinexor-Bortezomib-Dexamethasone in Previously Treated Multiple Myeloma
Michael Dolph, Gabriel Tremblay, Adrienne M Gilligan, et al.
Psychiatry Research
|
July 9, 2015
A randomised trial of nutrient supplements to minimise psychological stress after a natural disaster
Bonnie J Kaplan, Julia J Rucklidge, Amy R Romijn, et al.
ISRN Urology
|
September 13, 2013
ERG Protein Expression Is of Limited Prognostic Value in Men with Localized Prostate Cancer
Liang Hong Teng, Cheng Wang, Michael Dolph, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 4, 2012
ERG protein expression reflects hormonal treatment response and is associated with Gleason score and prostate cancer specific mortality
Tarek A Bismar, Michael Dolph, Liang-Hong Teng, et al.
Journal of Hematology & Oncology
|
March 11, 2014
Cysteine- rich secretory protein 3 (CRISP3), ERG and PTEN define a molecular subtype of prostate cancer with implication to patients' prognosis
Samir Al Bashir, Mohammed Alshalalfa, Samar A Hegazy, et al.
Future Oncology (London, England)
|
November 29, 2024
Survival trends using DPd vs. other triplets in early RRMM patients: a population-adjusted indirect treatment comparison
Faiz Anwer, Tommy Lan, Michael Dolph, et al.
Cancer Biology & Therapy
|
June 28, 2014
The prognostic significance of combined ERG and androgen receptor expression in patients with prostate cancer managed by androgen deprivation therapy
Kuo-Cheng Huang, Mohammed Alshalalfa, Samar A Hegazy, et al.
Urology
|
June 11, 2013
ERG protein expression and gene rearrangements are present at lower rates in metastatic and locally advanced castration-resistant prostate cancer compared to localized disease
Liang-Hong Teng, Cheng Wang, Louis R Bégin, et al.
Cancer Medicine
|
January 10, 2014
The significance of dynamin 2 expression for prostate cancer progression, prognostication, and therapeutic targeting
Bin Xu, Liang Hong Teng, Sabrina Daniela da Silva, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Pharmacoeconomics
|
August 9, 2021
Cost Effectiveness of Triplet Selinexor-Bortezomib-Dexamethasone (XVd) in Previously Treated Multiple Myeloma (MM) Based on Results from the Phase III BOSTON Trial
Michael Dolph, Gabriel Tremblay, Hoyee Leong
Journal of Health Economics and Outcomes Research
|
October 7, 2021
Network Meta-Analysis of Once Weekly Selinexor-Bortezomib-Dexamethasone in Previously Treated Multiple Myeloma
Michael Dolph, Gabriel Tremblay, Adrienne M Gilligan, et al.
Psychiatry Research
|
July 9, 2015
A randomised trial of nutrient supplements to minimise psychological stress after a natural disaster
Bonnie J Kaplan, Julia J Rucklidge, Amy R Romijn, et al.
ISRN Urology
|
September 13, 2013
ERG Protein Expression Is of Limited Prognostic Value in Men with Localized Prostate Cancer
Liang Hong Teng, Cheng Wang, Michael Dolph, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 4, 2012
ERG protein expression reflects hormonal treatment response and is associated with Gleason score and prostate cancer specific mortality
Tarek A Bismar, Michael Dolph, Liang-Hong Teng, et al.
Journal of Hematology & Oncology
|
March 11, 2014
Cysteine- rich secretory protein 3 (CRISP3), ERG and PTEN define a molecular subtype of prostate cancer with implication to patients' prognosis
Samir Al Bashir, Mohammed Alshalalfa, Samar A Hegazy, et al.
Future Oncology (London, England)
|
November 29, 2024
Survival trends using DPd vs. other triplets in early RRMM patients: a population-adjusted indirect treatment comparison
Faiz Anwer, Tommy Lan, Michael Dolph, et al.
Cancer Biology & Therapy
|
June 28, 2014
The prognostic significance of combined ERG and androgen receptor expression in patients with prostate cancer managed by androgen deprivation therapy
Kuo-Cheng Huang, Mohammed Alshalalfa, Samar A Hegazy, et al.
Urology
|
June 11, 2013
ERG protein expression and gene rearrangements are present at lower rates in metastatic and locally advanced castration-resistant prostate cancer compared to localized disease
Liang-Hong Teng, Cheng Wang, Louis R Bégin, et al.
Cancer Medicine
|
January 10, 2014
The significance of dynamin 2 expression for prostate cancer progression, prognostication, and therapeutic targeting
Bin Xu, Liang Hong Teng, Sabrina Daniela da Silva, et al.
Page
of 2